Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Massimo Iacobelli MD"'
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Defibrotide is approved to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) with renal/pulmonary dysfunction following hematopoietic cell transplantation (HCT) in adult and pediatric patients in the United States, and to
Externí odkaz:
https://doaj.org/article/d3fbf9b72f334a198d4e061a29d12963
Autor:
Sadeghi N; 1 Loyola University Medical Center, Maywood, IL, USA., Iacobelli M; 2 Massimo Iacobelli, MD - Techitra Srl - Milano, Italy., Vaziri B; 3 Pasteur Institute of Iran, Tehran, Iran., Kahn D; 1 Loyola University Medical Center, Maywood, IL, USA., Hoppensteadt D; 1 Loyola University Medical Center, Maywood, IL, USA., Guler N; 4 Ondokuz Mayis University, Samsun, Turkey., Fareed J; 1 Loyola University Medical Center, Maywood, IL, USA.
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2017 Apr; Vol. 23 (3), pp. 211-220. Date of Electronic Publication: 2016 Sep 24.